Kevin J. Harrington

3 ta ish

Institute of Cancer Research

1. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

   Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio +26

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.047644

2. Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

   Laura Evgin, Tim Kottke, Jason M. Tonne +18

   Maqola20223 iqtibos

   ABIABI:AkademIndex/2026.other.801856

3. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

   Lorenzo Galluzzi, Ilio Vitale, Sarah H. Warren +51

   Sharh maqolaOAOchiq kirish20202 iqtibos

   ABIABI:AkademIndex/2026.other.019933